NASDAQ:CVLB

Conversion Labs Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.
$8.25
-1.72 (-17.25 %)
(As of 04/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.10
Now: $8.25
$11.29
50-Day Range
$14.48
MA: $23.15
$30.55
52-Week Range
$0.50
Now: $8.25
$33.02
Volume3.38 million shs
Average Volume1.05 million shs
Market Capitalization$191.24 million
P/E RatioN/A
Dividend YieldN/A
Beta1.37

Competitors

Conversion Labs (NASDAQ:CVLB) Vs. AMCR, HI, ARRY, BRC, DAKT, and AGS

Should you be buying CVLB stock or one of its competitors? Companies in the industry of "miscellaneous manufacturing industries" are considered alternatives and competitors to Conversion Labs, including Amcor (AMCR), Hillenbrand (HI), Array Technologies (ARRY), Brady (BRC), Daktronics (DAKT), and PlayAGS (AGS).

Conversion Labs (NASDAQ:CVLB) and Amcor (NYSE:AMCR) are both retail/wholesale companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

Analyst Ratings

This is a summary of recent ratings and target prices for Conversion Labs and Amcor, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Conversion Labs00203.00
Amcor19202.08

Conversion Labs presently has a consensus price target of $37.50, indicating a potential upside of 354.55%. Amcor has a consensus price target of $12.40, indicating a potential upside of 4.55%. Given Conversion Labs' stronger consensus rating and higher probable upside, analysts clearly believe Conversion Labs is more favorable than Amcor.

Insider and Institutional Ownership

0.9% of Conversion Labs shares are owned by institutional investors. Comparatively, 35.0% of Amcor shares are owned by institutional investors. 27.9% of Conversion Labs shares are owned by insiders. Comparatively, 0.3% of Amcor shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Conversion Labs and Amcor's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conversion Labs$12.47 million15.34$-3,140,000.00N/AN/A
Amcor$12.47 billion1.49$612.20 million$0.6418.53

Amcor has higher revenue and earnings than Conversion Labs.

Volatility and Risk

Conversion Labs has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500. Comparatively, Amcor has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500.

Profitability

This table compares Conversion Labs and Amcor's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Conversion Labs-95.36%N/A-761.95%
Amcor6.00%18.75%5.57%

Summary

Amcor beats Conversion Labs on 7 of the 12 factors compared between the two stocks.

Conversion Labs (NASDAQ:CVLB) and Hillenbrand (NYSE:HI) are both retail/wholesale companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

Profitability

This table compares Conversion Labs and Hillenbrand's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Conversion Labs-95.36%N/A-761.95%
Hillenbrand-2.39%18.61%4.82%

Analyst Ratings

This is a summary of recent ratings and target prices for Conversion Labs and Hillenbrand, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Conversion Labs00203.00
Hillenbrand00203.00

Conversion Labs presently has a consensus price target of $37.50, indicating a potential upside of 354.55%. Hillenbrand has a consensus price target of $53.00, indicating a potential upside of 8.34%. Given Conversion Labs' higher probable upside, analysts clearly believe Conversion Labs is more favorable than Hillenbrand.

Valuation & Earnings

This table compares Conversion Labs and Hillenbrand's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conversion Labs$12.47 million15.34$-3,140,000.00N/AN/A
Hillenbrand$2.52 billion1.46$-60,100,000.00$3.1915.34

Conversion Labs has higher earnings, but lower revenue than Hillenbrand.

Insider and Institutional Ownership

0.9% of Conversion Labs shares are owned by institutional investors. Comparatively, 82.9% of Hillenbrand shares are owned by institutional investors. 27.9% of Conversion Labs shares are owned by insiders. Comparatively, 3.0% of Hillenbrand shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Volatility and Risk

Conversion Labs has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500. Comparatively, Hillenbrand has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500.

Summary

Hillenbrand beats Conversion Labs on 6 of the 11 factors compared between the two stocks.

Conversion Labs (NASDAQ:CVLB) and Array Technologies (NASDAQ:ARRY) are both retail/wholesale companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Profitability

This table compares Conversion Labs and Array Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Conversion Labs-95.36%N/A-761.95%
Array TechnologiesN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Conversion Labs and Array Technologies, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Conversion Labs00203.00
Array Technologies06702.54

Conversion Labs currently has a consensus price target of $37.50, indicating a potential upside of 354.55%. Array Technologies has a consensus price target of $47.4583, indicating a potential upside of 78.15%. Given Conversion Labs' stronger consensus rating and higher probable upside, equities research analysts clearly believe Conversion Labs is more favorable than Array Technologies.

Earnings and Valuation

This table compares Conversion Labs and Array Technologies' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conversion Labs$12.47 million15.34$-3,140,000.00N/AN/A
Array TechnologiesN/AN/AN/AN/AN/A

Array Technologies has lower revenue, but higher earnings than Conversion Labs.

Insider & Institutional Ownership

0.9% of Conversion Labs shares are held by institutional investors. 27.9% of Conversion Labs shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Conversion Labs beats Array Technologies on 5 of the 8 factors compared between the two stocks.

Conversion Labs (NASDAQ:CVLB) and Brady (NYSE:BRC) are both retail/wholesale companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Profitability

This table compares Conversion Labs and Brady's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Conversion Labs-95.36%N/A-761.95%
Brady10.11%13.80%10.22%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Conversion Labs and Brady, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Conversion Labs00203.00
Brady20202.00

Conversion Labs currently has a consensus price target of $37.50, indicating a potential upside of 354.55%. Brady has a consensus price target of $50.75, indicating a potential downside of 8.09%. Given Conversion Labs' stronger consensus rating and higher probable upside, equities research analysts clearly believe Conversion Labs is more favorable than Brady.

Earnings and Valuation

This table compares Conversion Labs and Brady's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conversion Labs$12.47 million15.34$-3,140,000.00N/AN/A
Brady$1.08 billion2.66$112.37 million$2.1126.17

Brady has higher revenue and earnings than Conversion Labs.

Insider & Institutional Ownership

0.9% of Conversion Labs shares are held by institutional investors. Comparatively, 74.9% of Brady shares are held by institutional investors. 27.9% of Conversion Labs shares are held by insiders. Comparatively, 15.6% of Brady shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

Conversion Labs has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500. Comparatively, Brady has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500.

Summary

Brady beats Conversion Labs on 7 of the 12 factors compared between the two stocks.

Conversion Labs (NASDAQ:CVLB) and Daktronics (NASDAQ:DAKT) are both small-cap retail/wholesale companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Profitability

This table compares Conversion Labs and Daktronics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Conversion Labs-95.36%N/A-761.95%
Daktronics-0.56%-1.59%-0.79%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Conversion Labs and Daktronics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Conversion Labs00203.00
Daktronics0000N/A

Conversion Labs currently has a consensus price target of $37.50, indicating a potential upside of 354.55%. Given Conversion Labs' higher probable upside, equities research analysts clearly believe Conversion Labs is more favorable than Daktronics.

Earnings and Valuation

This table compares Conversion Labs and Daktronics' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conversion Labs$12.47 million15.34$-3,140,000.00N/AN/A
Daktronics$608.93 million0.65$490,000.00N/AN/A

Daktronics has higher revenue and earnings than Conversion Labs.

Insider & Institutional Ownership

0.9% of Conversion Labs shares are held by institutional investors. Comparatively, 39.2% of Daktronics shares are held by institutional investors. 27.9% of Conversion Labs shares are held by insiders. Comparatively, 8.3% of Daktronics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

Conversion Labs has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500. Comparatively, Daktronics has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500.

Summary

Conversion Labs beats Daktronics on 7 of the 12 factors compared between the two stocks.

Conversion Labs (NASDAQ:CVLB) and PlayAGS (NYSE:AGS) are both small-cap retail/wholesale companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Profitability

This table compares Conversion Labs and PlayAGS's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Conversion Labs-95.36%N/A-761.95%
PlayAGS-33.66%-67.28%-8.34%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Conversion Labs and PlayAGS, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Conversion Labs00203.00
PlayAGS03502.63

Conversion Labs currently has a consensus price target of $37.50, indicating a potential upside of 354.55%. PlayAGS has a consensus price target of $8.8571, indicating a potential upside of 17.31%. Given Conversion Labs' stronger consensus rating and higher probable upside, equities research analysts clearly believe Conversion Labs is more favorable than PlayAGS.

Earnings and Valuation

This table compares Conversion Labs and PlayAGS's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conversion Labs$12.47 million15.34$-3,140,000.00N/AN/A
PlayAGS$304.71 million0.90$-11,750,000.00($0.19)-39.74

Conversion Labs has higher earnings, but lower revenue than PlayAGS.

Insider & Institutional Ownership

0.9% of Conversion Labs shares are held by institutional investors. Comparatively, 79.4% of PlayAGS shares are held by institutional investors. 27.9% of Conversion Labs shares are held by insiders. Comparatively, 2.8% of PlayAGS shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

Conversion Labs has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500. Comparatively, PlayAGS has a beta of 3.48, suggesting that its share price is 248% more volatile than the S&P 500.

Summary

Conversion Labs beats PlayAGS on 7 of the 13 factors compared between the two stocks.


Conversion Labs Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Amcor logo
AMCR
Amcor
2.0$11.86-0.8%$18.53 billion$12.47 billion18.53
Hillenbrand logo
HI
Hillenbrand
2.0$48.92-2.4%$3.67 billion$2.52 billion-60.39
Array Technologies logo
ARRY
Array Technologies
1.6$26.64-4.1%$3.38 billionN/A0.00
Brady logo
BRC
Brady
2.2$55.22-0.3%$2.87 billion$1.08 billion26.94Decrease in Short Interest
Daktronics logo
DAKT
Daktronics
0.7$6.29-1.9%$394.70 million$608.93 million-125.80
PlayAGS logo
AGS
PlayAGS
1.6$7.55-2.6%$275.10 million$304.71 million-4.02
Oil-Dri Co. of America logo
ODC
Oil-Dri Co. of America
1.2$34.56-0.6%$256.78 million$283.23 million13.14
VirTra logo
VTSI
VirTra
1.5$5.11-1.2%$39.73 million$18.71 million-255.37
Sigma Labs logo
SGLB
Sigma Labs
1.2$3.16-1.3%$33.16 million$400,000.000.00Gap Down
Summer Infant logo
SUMR
Summer Infant
0.9$9.35-7.9%$19.94 million$173.18 million14.38Gap Up
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.